Heartbeam Net Worth
Heartbeam Net Worth Breakdown | BEAT |
Heartbeam Net Worth Analysis
Heartbeam's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Heartbeam's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Heartbeam's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Heartbeam's net worth analysis. One common approach is to calculate Heartbeam's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Heartbeam's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Heartbeam's net worth. This approach calculates the present value of Heartbeam's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Heartbeam's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Heartbeam's net worth. This involves comparing Heartbeam's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Heartbeam's net worth relative to its peers.
Enterprise Value |
|
To determine if Heartbeam is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Heartbeam's net worth research are outlined below:
| Heartbeam generated a negative expected return over the last 90 days | |
| Heartbeam has high historical volatility and very poor performance | |
| Net Loss for the year was (14.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heartbeam currently holds about 9.27 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16. | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: HeartBeam Announces Pricing of 10.0 Million Underwritten Public Offering of Common Stock |
Heartbeam Quarterly Good Will |
|
Heartbeam uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Heartbeam. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Heartbeam's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Heartbeam's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Heartbeam is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heartbeam backward and forwards among themselves. Heartbeam's institutional investor refers to the entity that pools money to purchase Heartbeam's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Spectrum Asset Management Inc | 2024-12-31 | 74.4 K | State Street Corp | 2024-09-30 | 69.6 K | Advisory Research Inc | 2024-09-30 | 50 K | Northern Trust Corp | 2024-09-30 | 46.8 K | D'orazio & Associates Inc | 2024-12-31 | 33 K | Smart Wealth Llc | 2024-12-31 | 25 K | Two Sigma Securities, Llc | 2024-09-30 | 23.9 K | Xtx Topco Ltd | 2024-09-30 | 14.6 K | Charles Schwab Investment Management Inc | 2024-12-31 | 14.5 K | Vanguard Group Inc | 2024-09-30 | 750.7 K | Smith, Salley & Associates, Llc | 2024-12-31 | 250 K |
Follow Heartbeam's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.8 M.Market Cap |
|
Project Heartbeam's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.98) | (1.03) | |
| Return On Capital Employed | (1.11) | (1.05) | |
| Return On Assets | (0.98) | (1.03) | |
| Return On Equity | (1.06) | (1.00) |
When accessing Heartbeam's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Heartbeam's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Heartbeam's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Heartbeam's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heartbeam. Check Heartbeam's Beneish M Score to see the likelihood of Heartbeam's management manipulating its earnings.
Evaluate Heartbeam's management efficiency
Heartbeam has return on total asset (ROA) of (0.9053) % which means that it has lost $0.9053 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5723) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.03 in 2025. Return On Capital Employed is likely to gain to -1.05 in 2025. Change To Liabilities is likely to gain to about 1.9 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 18.7 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.71 | 0.67 | |
| Tangible Book Value Per Share | 0.71 | 0.74 | |
| Enterprise Value Over EBITDA | 53.83 | 56.52 | |
| Price Book Value Ratio | 3.45 | 3.62 | |
| Enterprise Value Multiple | 53.83 | 56.52 | |
| Price Fair Value | 3.45 | 3.62 | |
| Enterprise Value | 32.6 M | 45.9 M |
Evaluating the management effectiveness of Heartbeam allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Heartbeam Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heartbeam insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heartbeam's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heartbeam insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Heartbeam Corporate Filings
| 14th of February 2025 Other Reports | ViewVerify | |
FWP | 8th of January 2025 A written communication used by offering participants to offer securities to the public or to solicit securities transactions. | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Heartbeam Earnings per Share Projection vs Actual
Heartbeam Corporate Management
| Branislav Vajdic | President, Founder | Profile | |
| FACC MD | Chief Officer | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Richard Brounstein | CFO Treasurer | Profile | |
| Richa Gujarati | Senior Product | Profile | |
| Kenneth Persen | Chief Officer | Profile |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.